These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34003452)

  • 1. Patients with Congenital Low-Flow Vascular Malformation Treated with Low Dose Sirolimus.
    Harbers VEM; Rongen GAPJM; van der Vleuten CJM; Verhoeven BH; de Laat PCJ; van der Horst CMAM; Klein WM; Schultze Kool LJ; Loo DMWMT
    Adv Ther; 2021 Jun; 38(6):3465-3482. PubMed ID: 34003452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirolimus (Rapamycin) for Slow-Flow Malformations in Children: The Observational-Phase Randomized Clinical PERFORMUS Trial.
    Maruani A; Tavernier E; Boccara O; Mazereeuw-Hautier J; Leducq S; Bessis D; Guibaud L; Vabres P; Carmignac V; Mallet S; Barbarot S; Chiaverini C; Droitcourt C; Bursztejn AC; Lengellé C; Woillard JB; Herbreteau D; Le Touze A; Joly A; Léauté-Labrèze C; Powell J; Bourgoin H; Gissot V; Giraudeau B; Morel B
    JAMA Dermatol; 2021 Nov; 157(11):1289-1298. PubMed ID: 34524406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study.
    Hammer J; Seront E; Duez S; Dupont S; Van Damme A; Schmitz S; Hoyoux C; Chopinet C; Clapuyt P; Hammer F; Vikkula M; Boon LM
    Orphanet J Rare Dis; 2018 Oct; 13(1):191. PubMed ID: 30373605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of voluminous and complicated superficial slow-flow vascular malformations with sirolimus (PERFORMUS): protocol for a multicenter phase 2 trial with a randomized observational-phase design.
    Maruani A; Boccara O; Bessis D; Guibaud L; Vabres P; Mazereeuw-Hautier J; Barbarot S; Chiaverini C; Blaise S; Droitcourt C; Mallet S; Martin L; Lorette G; Woillard JB; Jonville-Bera AP; Rollin J; Gruel Y; Herbreteau D; Goga D; le Touze A; Leducq S; Gissot V; Morel B; Tavernier E; Giraudeau B;
    Trials; 2018 Jun; 19(1):340. PubMed ID: 29945674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single Center Experience of Sirolimus Therapy in Head and Neck Low-flow Vascular Malformations.
    Pang C; Evans N; Jethwa P; Papadopoulou A; Khalifa M; Tsui J; Hamilton G; Lim CS; Brookes J
    Vasc Endovascular Surg; 2021 Jul; 55(5):482-490. PubMed ID: 33878964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of sirolimus in children with lymphatic malformations of the head and neck.
    Wiegand S; Dietz A; Wichmann G
    Eur Arch Otorhinolaryngol; 2022 Aug; 279(8):3801-3810. PubMed ID: 35526176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A narrative review of the role of sirolimus in the treatment of congenital vascular malformations.
    Geeurickx M; Labarque V
    J Vasc Surg Venous Lymphat Disord; 2021 Sep; 9(5):1321-1333. PubMed ID: 33737259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of oral sirolimus for high-flow vascular malformations in real clinical practice.
    Durán-Romero AJ; Hernández-Rodríguez JC; Ortiz-Álvarez J; Domínguez-Cruz JJ; Monserrat-García MT; Conejo-Mir Sánchez J; Bernabeu-Wittel J
    Clin Exp Dermatol; 2022 Jan; 47(1):57-62. PubMed ID: 34240451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and absorption of topical sirolimus for the treatment of vascular anomalies in children: A case series.
    Le Sage S; David M; Dubois J; Powell J; McCuaig CC; Théorêt Y; Kleiber N
    Pediatr Dermatol; 2018 Jul; 35(4):472-477. PubMed ID: 29790593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical differences in sirolimus treatment with low target levels between children and adults with vascular malformations - A nationwide trial.
    Harbers VEM; Zwerink LGJM; Rongen GA; Klein WM; van der Vleuten CJM; van Rijnsoever IMP; Gerdsen-Drury L; Flucke UE; Verhoeven BH; de Laat PCJ; van der Horst CMAM; Schultze Kool LJ; Te Loo DMWM
    Clin Transl Sci; 2023 May; 16(5):781-796. PubMed ID: 36824030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral rapamycin: an alternative in children with complicated vascular abnormalities.
    Gómez Sánchez A; Redondo Sedano JV; Pérez Alonso V; Martí Carrera ME; Baro Fernández M; Palencia Pérez SI; Gallego Herrero MC; Gómez Fraile A; Delgado Muñoz MD
    Cir Pediatr; 2020 Oct; 33(4):183-187. PubMed ID: 33016658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of sirolimus therapy on lesion size, clinical symptoms, and quality of life of patients with lymphatic anomalies.
    Ozeki M; Nozawa A; Yasue S; Endo S; Asada R; Hashimoto H; Fukao T
    Orphanet J Rare Dis; 2019 Jun; 14(1):141. PubMed ID: 31196128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Use of Sirolimus for Treatment of Orbital Lymphatic Malformations: A Systematic Review.
    Shoji MK; Shishido S; Freitag SK
    Ophthalmic Plast Reconstr Surg; 2020; 36(3):215-221. PubMed ID: 31990892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirolimus treatment for paediatric head and neck lymphatic malformations: a systematic review.
    Saibene AM; Rosso C; Felisati G; Pignataro L; Schindler A; Ghilardi G; Colletti G; Gaffuri M; Mozzanica F
    Eur Arch Otorhinolaryngol; 2023 Aug; 280(8):3529-3540. PubMed ID: 37115326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to sirolimus in capillary lymphatic venous malformations and associated syndromes: Impact on symptomatology, quality of life, and radiographic response.
    Engel ER; Hammill A; Adams D; Phillips RJ; Jeng M; Tollefson MM; Iacobas I; Schiff D; Greenberger S; Kelly M; Frieden I; Zaghloul N; Drolet B; Geddis A; Goldenberg D; Ricci K
    Pediatr Blood Cancer; 2023 Apr; 70(4):e30215. PubMed ID: 36651691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective multicenter study of sirolimus for complicated vascular anomalies.
    Ji Y; Chen S; Yang K; Zhou J; Zhang X; Jiang X; Xu X; Lu G; Qiu L; Kong F; Zhang Y
    J Vasc Surg; 2021 Nov; 74(5):1673-1681.e3. PubMed ID: 34082006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-center experience with sirolimus therapy for vascular malformations.
    Yesil S; Tanyildiz HG; Bozkurt C; Cakmakci E; Sahin G
    Pediatr Hematol Oncol; 2016 Apr; 33(3):219-25. PubMed ID: 27128161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-World Data on the Use of Sirolimus in Asian Children with Vascular Malformations.
    Yu L; Xu Z; Wei L; Zhang B; Qiu L; Ma L; Li L
    Paediatr Drugs; 2024 May; 26(3):309-317. PubMed ID: 38280106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral Sirolimus: An Option in the Management of Neonates with Life-Threatening Upper Airway Lymphatic Malformations.
    Triana P; Miguel M; Díaz M; Cabrera M; López Gutiérrez JC
    Lymphat Res Biol; 2019 Oct; 17(5):504-511. PubMed ID: 30985248
    [No Abstract]   [Full Text] [Related]  

  • 20. Sirolimus for the treatment of children with various complicated vascular anomalies.
    Lackner H; Karastaneva A; Schwinger W; Benesch M; Sovinz P; Seidel M; Sperl D; Lanz S; Haxhija E; Reiterer F; Sorantin E; Urban CE
    Eur J Pediatr; 2015 Dec; 174(12):1579-84. PubMed ID: 26040705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.